Koch, J.; Mönch, D.; Maaß, A.; Mangold, A.; Gužvić, M.; Mürdter, T.; Leibold, T.; Dahlke, M.-H.; Renner, P.
Pharmacologic Targeting of MMP2/9 Decreases Peritoneal Metastasis Formation of Colorectal Cancer in a Human Ex Vivo Peritoneum Culture Model. Cancers 2022, 14, 3760.
https://doi.org/10.3390/cancers14153760
AMA Style
Koch J, Mönch D, Maaß A, Mangold A, Gužvić M, Mürdter T, Leibold T, Dahlke M-H, Renner P.
Pharmacologic Targeting of MMP2/9 Decreases Peritoneal Metastasis Formation of Colorectal Cancer in a Human Ex Vivo Peritoneum Culture Model. Cancers. 2022; 14(15):3760.
https://doi.org/10.3390/cancers14153760
Chicago/Turabian Style
Koch, Jana, Dina Mönch, Annika Maaß, Alina Mangold, Miodrag Gužvić, Thomas Mürdter, Tobias Leibold, Marc-H. Dahlke, and Philipp Renner.
2022. "Pharmacologic Targeting of MMP2/9 Decreases Peritoneal Metastasis Formation of Colorectal Cancer in a Human Ex Vivo Peritoneum Culture Model" Cancers 14, no. 15: 3760.
https://doi.org/10.3390/cancers14153760
APA Style
Koch, J., Mönch, D., Maaß, A., Mangold, A., Gužvić, M., Mürdter, T., Leibold, T., Dahlke, M. -H., & Renner, P.
(2022). Pharmacologic Targeting of MMP2/9 Decreases Peritoneal Metastasis Formation of Colorectal Cancer in a Human Ex Vivo Peritoneum Culture Model. Cancers, 14(15), 3760.
https://doi.org/10.3390/cancers14153760